1. Real-Life Analysis of Efficacy and Safety of Everolimus Plus Exemestane in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Patients: A Turkish Oncology Group (TOG) Study. (7th February 2022) Authors: Bilici, Ahmet; Uysal, Mukremin; Menekse, Serkan; Akin, Semih; Yildiz, Fatih; Turan, Merve; Sezgin Goksu, Sema; Beypinar, Ismail; Sakalar, Teoman; Değirmenci, Mustafa; Erdem, Dilek; Basaran, Gul; Olmez, Omer Fatih; Avci, Nilufer; Tural, Deniz; Sakin, Abdullah; Turker, Sema; Demir, Atakan; Temiz, S... Journal: Cancer investigation Issue: Volume 40:Number 2(2022) Page Start: 199 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗